Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07538167Not ApplicableNot Yet Recruiting

Food Trial Evaluating Fecal Abundance of SBD111 With Once-Daily Versus Twice-Daily Administration in Healthy Adults

Role: lead

NCT06389539Not ApplicableRecruiting

Synbiotic to Attenuate Resorption of the Skeleton

Role: collaborator

NCT06005220Not ApplicableCompleted

SBD121, a Synbiotic Medical Food for RA Management

Role: lead

NCT06614166Not ApplicableActive Not Recruiting

Food Trial to Evaluate the Kinetics of the Medical Foods SBD111 and SBD121 Persistence in Healthy Adults

Role: lead

NCT05009875Not ApplicableCompleted

Food Trial Evaluating the Efficacy of SBD111 Versus Placebo for the Clinical Dietary Management of the Metabolic Processes of Osteopenia

Role: lead

NCT05206864Not ApplicableCompleted

Food Trial to Evaluate the Safety and Tolerability of SBD111 in Health Adults

Role: lead

All 6 trials loaded